Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL-Reference-Cited by-同舟云学术

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL

Published:2013-02-03 Issue:3 Volume:19 Page:368-371
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Tzoneva Gannie,Perez-Garcia Arianne,Carpenter Zachary,Khiabanian Hossein,Tosello Valeria,Allegretta Maddalena,Paietta Elisabeth,Racevskis Janis,Rowe Jacob M,Tallman Martin S,Paganin Maddalena,Basso Giuseppe,Hof Jana,Kirschner-Schwabe Renate,Palomero Teresa,Rabadan Raul,Ferrando Adolfo

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3078.pdf

Reference37 articles.

1. Möricke, A. et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24, 265–284 (2010).

2. Salzer, W.L. et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children′s oncology group. Leukemia 24, 355–370 (2010).

3. Koren, G. et al. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N. Engl. J. Med. 323, 17–21 (1990).

4. Relling, M.V., Hancock, M.L., Boyett, J.M., Pui, C.H. & Evans, W.E. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93, 2817–2823 (1999).

5. Pui, C.H. & Evans, W.E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166–178 (2006).

Cited by 284 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy;Clinical Pharmacokinetics;2024-07-20

2. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

3. Early response and outcomes of bone marrow to chemotherapy in T-Cell Acute Lymphoblastic Leukemia;Pakistan Journal of Medical Sciences;2024-03-18

4. Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL;Blood;2024-03-07

5. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?;Cancer and Metastasis Reviews;2024-03